Key Findings:  CBG and CBDV produced efficacy in models of Huntington's disease and epilepsy. CBC, Δ9‐THC, and THCV showed promise in models of seizure, hypomobility, Huntington's and Parkinson's disease
Type of Study:  Meta-analysis
Study Result:  Positive
Research Location(s):  United Kingdom
Year of Pub:  2020
Cannabinoids Studied:  Cannabichromene (CBC), Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Cannabis Flower derived
Citation:  Stone NL, et al. A systematic review of minor phytocannabinoids with promising neuroprotective potential. Br J Pharmacol. 2020; 177:4330-4352. doi: 10.1111/bph.15185
Authors:  Stone NL, Murphy AJ, England TJ, O'Sullivan SE